2011-10-07
(WASHINGTON) - The American Society of Hematology (ASH) today announced the 11 hematologists and medical professionals from developing countries selected to participate in the Society’s 2011 Visitor Training Program. This program provides funds for hematologists and medical professionals from developing nations to train on a specific topic or technique under the mentorship of an ASH member anywhere in the world for up to 12 weeks. Once participants complete their training, they return to their home institutions to implement what they have learned and share their new skills with colleagues.
“The Visitor Training Program provides these talented doctors and scientists from developing countries with a valuable opportunity to learn new and advanced approaches to patient care and research that they do not have at their home hospitals or research institutions,” said ASH President J. Evan Sadler, MD, PhD, of the Washington University School of Medicine in St. Louis. “By providing program participants with specialized, individualized training that they can implement at their home institutions, ASH is helping to increase the quality of hematologic care in underserved areas around the world.”
The 2011 ASH VTP participants are:
| Recipient |
Training |
Mentor/Institution |
Walter Gabriel Borelli Piedras, MD
Uruguay |
Clinical care of chronic graft-versus-host disease (cGVHD) patients. |
Dr. Marcos J.G. De Lima, MD
University of Texas, Houston, TX |
Lallindra Viranjan Gooneratne MD, MBBS, FRCPath
Sri Lanka |
Flow cytometry in hematologic malignancies. |
Stephen Devereux, PhD, FRCP, FRCPath
King’s College Hospital, London, UK |
Naima Islam, MBBS, FCPS (Hematology)
Bangladesh |
Treatment protocols and procedures for leukemia. |
Vikas Gupta, MD, FRCP, FRCPath
Princess Margaret Hospital, Toronto, Ontario, CA |
Ana Ilda Ayala Lugo, PhD, MsC
Paraguay |
Training in immunofluorescence with anti-PML, RT-PCR, qRT-PCR and FISH diagnostic and disease monitoring with emphasis in acute promyelocytic leukemia (APL). |
Eduardo Magalhães Rego, MD, PhD
University of São Paulo, Medical, São Paulo, Brazil |
Muhammad Nadeem, MBBS, MCPS, FCPS (Hematology)
Pakistan |
Techniques involved in diagnosis and management of suspected cases of myelodysplastic syndromes (MDS). |
Azra Raza, MD
Columbia University, New York, NY |
Ninoska Rojas Soto, MD
Peru |
Data banking and management of acute promyelocytic leukemia (APL) cases. |
Eduardo Magalhães Rego, MD, PhD
University of São Paulo, Medical, São Paulo, Brazil |
Humayoon Shafique Satti, M. Phil
Pakistan |
Stem cell culture techniques. |
Rupert Handgretinger, MD
Children’s University Hospital, Tübingen, Germany |
Manju Sengar, MD, DM
India |
Gene expression profiling (microarray methodology and data analysis). |
Sandeep Dave, MD, MS
Duke University, Durham, NC |
Alain Nsabimana Uwumugambi, MD
Rwanda |
Assessment of the morphology of peripheral blood work and bone marrow aspirates. |
Leslie Lehmann, MD
Dana-Farber Cancer Institute, Boston, MA |
Rafil Toma Hurmiz Yaqo, MBChB, FIBMS
Iraq |
Latest developments in the diagnostics of malignant lymphomas. |
Aliyah R. Sohani, MD
Massachusetts General Hospital, Boston, MA |
Dina Yassin, MD
Egypt |
Gene sequencing and analysis to improve the evaluation and treatment of pediatric leukemias in Egypt. |
Lia Gore, MD
Children’s Hospital Colorado, Aurora, CO |
The Visitor Training Program is designed for hematologists and scientists in developing countries at any level in their careers. In addition to being paired with a mentor, each participant is paired with a member of the ASH International Members Committee, who assists in the development of participants’ programs and implementation of their new expertise at their home institutions following their training.
To arrange an interview with a Visitor Training Program participant or mentor, please contact Lindsey Love, ASH Communications Assistant, at 202-552-4925 or llove@hematology.org.
The American Society of Hematology is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
back to top
